Table 2.

Median facility-level percentage of patients using calcimimetics by region and facility type, 2018

GeographyFacility TypeNumber of FacilitiesMedian Facility-Level Percentage of Patients Who Are Dialysis Dependent and Using CalcimimeticsInterquartile Range (%)
United StatesLDO52672213
SDO and other12191820
Midwest Census RegionLDO12642013
SDO and other3171918
Northeast Census RegionLDO6352515
SDO and other2291921
South Census RegionLDO25042414
SDO and other4251925
West Census RegionLDO8641911
SDO and other2481714
  • Calcimimetic use is defined as having at least 90 d of calcimimetic use, without a gap of no more than 60 d between any consecutive administrations. LDO facilities represent DaVita or Fresenius facilities; MDO facilities represent Dialysis Clinic Inc., US Renal Care, American Renal Associates, and Satellite Healthcare facilities; remainder of facilities are classified as SDO and other. LDO, large dialysis organization; MDO, medium dialysis organization; SDO, small dialysis organization.